In the current literatures, SPNS3 is recognized as an atypical solute carrier belonging to the major facilitator superfamily type [21] and participates in sphingolipid pathways to regulate airway hyperresponsiveness and mast cell activation in asthma patients [22]. This evidence concerns the gene SPNS3 and asthma.